Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wallace, K. B.
Right arrow Articles by York, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallace, K. B.
Right arrow Articles by York, M. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity

Kendall B. Wallace

Member of the Expert Working Group , kwallace{at}d.umn.edu, Chair of the Expert Working Group and Corresponding Author, Professor, Department of Biochemistry & Molecular Biology, University of Minnesota School of Medicine, Duluth, MN

Elizabeth Hausner

FDA Liaison, FDA Center for Drug Evaluation and Research, Rockville, MD 20852

Eugene Herman

Center for Drug Evaluation and Research, FDA, Laurel, MD 20708

Gordon D. Holt

Principal Scientist, Oxford GlycoSciences, Montgomery Village, MD 20886-1265

James T. Macgregor

FDA Liaison, FDA National Center for Toxicological Research, Rockville, MD 20857

Alan L. Metz

Drug Safety Evaluation, Global Research and Development, Ann Arbor Laboratories, Pfizer Inc., Ann Arbor, MI 48105

Elizabeth Murphy

Laboratory of Molecular Carcinogenesis, National Institutes of Environmental Health Sciences, Research Triangle Park, NC 27709

I.Y. Rosenblum

Director, General Toxicology, Drug Safety and Metabolism, Schering-Plough Research Institute, Lafayette, NJ 07848

Frank D. Sistare

FDA Liaison, Center for Drug Evaluation and Research, FDA, Laurel, MD 20708

Malcolm J. York

Clinical Pathology Laboratory, Preclinical Safety Sciences, GlaxoSmithKline, Hertfordshire, SG12, ODP, United Kingdom

References

  • Adamcova, M., V. Gersl, R. Hrdina, M. Melka, Y. Mazurove, J. Vavrova, V. Palicka, and Z. Kokstein (1999a). "Cardiac Troponin T as a Marker of Myocardial Damage Caused by Antineoplastic Drugs in Rabbits." J Cancer Res Clin Oncol 125: 268—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Adamcova, M., Z. Kokstein, V. Palicka, J. Vavrova, M. Kostal, M. Podholova, and P. Kalons (1999b). "Cardiac Troponin T in Pregnant Women Having Intravenous Tocolytic Therapy." Arch Gynecol Obstet 262: 121—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Adams, J.III, D. Abendschein, and A. Jaffe (1990). "Biochemical Markers of Myocardial Injury. Is MB Creatine Kinase the Choice for the 1990's?" Circulation 88: 750—63.
  • Ammann P., T. Fehr, E.I. Minder, C. Gunter, and O. Bertel (2001). "Elevation of Troponin I in Sepsis and Septic Shock." Intensive Care Med 27: 965—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Amos, L. (1985). "Structure of Muscle Filaments Studied by Electron Microscopy." Ann Rev Biophys Biophys Chem 14: 291—313.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Anderson, P.A.W., N.N. Malouf, A.E. Oakeley, E.D. Pagani, and P.D. Allen (1991). "Troponin Isoform Expression in Humans: A Comparison Among Normal and Failing Adult Heart, Fetal Heart and Adult and Fetal Skeletal Muscle." Circ Res 69: 1226—33.[Abstract/Free Full Text]
  • Antman, E.M. and E. Braunwald (2001). Acute myocardial infarction. Heart Disease. E. Braunwald, D. P. Zipes, and P. Libby. WB Saunders, Philadelphia.
  • Apple, F.S. (1999a). "Creatine Kinase Isoforms and Myoglobin: Early Detection of Myocardial Infarction and Reperfusion." Coron Artery Dis 10: 75—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Apple, F.S. (1999b). "Tissue Specificity of Cardiac Troponin I, Cardiac Troponin T and Creatine Kinase-MB." Clin Chim Acta 284: 151—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Berson, G., J.L. Samuel, and B. Swynghedauw (1978). "A Comparative Study of the cTnI Factor from Mammalians." Pflugers Arch 374: 277—83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bertinchant, J.P., A. Polge, B. Ledermann, L. Genet, P. Fabbro-Peray, F. Raczka, J. Brunet, S. Poirey, O. Wittenberg, I. Pernel, and J. Nigond (1999b). "Relation of Minor Cardiac Troponin I Elevation to Late Cardiac Events after Uncomplicated Elective Successful Percutaneous Transluminal Coronary Angioplasty for Angina Pectoris." Am J Cardiol 84: 51—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bertinchant, J.P., A. Polge, E. Robert, N. Sabbah, P. Fabbro-Peray, S. Poirey, M. Laprade, B. Pau, J. M. Juan, J. P. Bali, J. E., de la Coussaye, and M. Dauzat ( 1999c). "Time-Course of Cardiac Troponin I Release from Isolated Perfused Rat Hearts During Hypoxia/Reoxygenation and Ischemia/Reperfusion." Clin Chim Acta 283: 43—56.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bertinchant, J.P., E. Robert, A. Polge, C. Marty-Double, P. Fabbro-Peray, S. Poirey, G. Aya, J.M. Juan, B. Lederman, J.E. de la Coussaye, and M. Dauzat, (2000). "Comparison of the Diagnostic Value of Cardiac Troponin I and T Determinations for Detecting Early Myocardial Damage and the Relationship with Histological Findings after Isoprenaline-induced Cardiac Injury in rats. Clin Chim Acta 298: 13—28.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bertinchant, J.P., E. Robert, A. Polge, J.E. de la Coussaye, C. Pignodel, G. Aya, P. Fabbro-Peray, S. Poirey, B. Ledermann, J.J. Eledjam, and M. Dauzat (1999a). "Release Kinetics of Cardiac Troponin I and Cardiac Troponin T in Effluents from Isolated Perfused Rabbit Hearts after Graded Experimental Myocardial Contusion." J Trauma 47: 474—80.[Web of Science][Medline] [Order article via Infotrieve]
  • Bertsch, T., H. Bleuel, J. Aufenanger, and W. Rebel (1997). "Comparison of Cardiac Troponin T and Cardiac Troponin I Concentrations in Peripheral Blood During Orciprenaline Induced Tachycardia in Rats." Exp Toxicol Pathol 49: 467—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Bleier, J., K.P. Vorderwinkler, J. Falkensammer, P. Mair, O. Dapunt, B. Puschendorf, and J. Mair (1998). "Different Intracellular Compartmentations of Cardiac Troponins and Myosin Heavy Chains: A Causal Connection to their Different Early Release after Myocardial Damage." Clin Chem 44: 1912—8.[Abstract/Free Full Text]
  • Bleuel, H., U. Deschl, T. Bertsch, G. Bolz, and W. Rebel (1995). "Diagnostic Efficiency of Troponin T Measurements in Rats with Experimental Myocardial Cell Damage." Exp Tox Pathol 47: 121—7.
  • Bodor, G.S. (1994). "Cardiac Troponin I. A Highly Specific Biochemical Marker or Myocardial Infarction." J Clin Immunoassay 17: 40—4.
  • Bodor, G.S., D. Porterfield, E.M. Voss, S. Smith, and F.S. Apple (1995). "Cardiac Troponin I is Not Expressed in Fetal and Healthy or Diseased Adult Human Skeletal Muscle. Clin Chem 41: 1710—1715.[Abstract]
  • Bodor, G.S., D. Porterfield, E.M. Voss, S. Smith, and F.S. Apple (1997). "Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 43: 476—84.[Abstract/Free Full Text]
  • Bohner, J., K.W. vonPape, W. Hannes, and T. Stegmann (1996). "False-Negative Immunoassay Results for Cardiac Troponin I Probably due to Circulating Troponin I Autoantibodies." Clin Chem 42: 2046.[Free Full Text]
  • Bonvenuto, G.M., L. La Vecchia, P. Morandi, P. Ruffini, and G. Mezzena (2000). "Assessment of Cardiotoxicity of High Dose Cyclophosphomide with Electrocardiographic, Echocardiographic, and Troponin I Monitoring in Patients with Breast Tumors." Italia Heart J Off J Ital Fed Cardiol 1 (Suppl 11): 1457—63.
  • Braun, S.L., D.E. Pongratz, P. Bialk, S. Liem, B. Schlotter, and W. Vogt (1996). "Discrepant Results for Cardiac Troponin T and Troponin I in Chronic Myopathy Depending on Instrument and Assay Generation." Clin Chem 42: 2039—41.[Free Full Text]
  • Cantwell, R.V., R.J. Aviles, J. Bjornsson, R.S. Wright, W.K. Freeman, J.K. Oh, J.D. Hoyer, S. Markovic, and A.S. Jaffe (2002). "Cardiac Amyloidosis Presenting with Elevations of Cardiac Troponin I and Angina pectoris." Clin Cardiol 25(1): 33—7.[Web of Science][Medline] [Order article via Infotrieve]
  • Cheesebro, M.J. (1997). "Using Serum Markers in the Early Diagnosis of Myocardial Infarction." Am Fam Phys 55: 2667—74.[Web of Science][Medline] [Order article via Infotrieve]
  • Chiang, V.W., J.P. Burns, N. Rifai, S.E. Lipshultz, J. Adamson, and D.L. Weiner (2000). "Cardiac Toxicity of Intravenous Terbutaline for the Treatment of Severe Asthma in Children: A Prospective Assessment." J Ped 137(1): 73—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Childs, A.C., S.L. Phaneuf, A.J. Dirks, T. Phillips, and C. Leeuwenburgh (2002). "Doxorubicin Treatment in vivo Causes Cytochrome C Release and Cardiomyocyte Apoptosis as Well as Increased Mitochondrial Efficiency, Superoxide Dismutase Activity and Bcl-:Bax Ratio." Cancer Res 62: 4592—8.[Abstract/Free Full Text]
  • Christenson, R.H., S. Hong Duh, F.S. Apple, G.S. Bodor, D.M. Bunk, J. Dalluge, M. Panteghini, J.D. Potter, M.J. Welch, A.H. Wu and S.E. Kahn (2001). "Standardisation of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference Materials." Clin Chem 47: 431—7.[Abstract/Free Full Text]
  • Christenson, R.H., L.K. Mewby, and E.M. Ohman (1997). "Cardiac Markers in the Assessment of Acute Coronary Syndromes." Md Med J Suppl: 18—24.
  • Christansen, S., K. Redmann, H.H. Scheld, V.R. Jahn, J. Stypmann, M. Fobker, A.D. Gruber, and D. Hammel (2002). "Adriamycin-Induced Cardiomyopathy in the Dog—An Appropriate Model for Research on Partial Left Ventriculectomy. J Heart Lung Transpl 21: 783—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chu, W.W., R.S. Dieter, and C.K. Stone (2002). "A Review of Clinically Relevant Cardiac Biochemical Markers." Wisconsin Med J 101: 40—8.
  • Collinson, P.O., F.G. Boa, and D.C. Gaze (2001). "Measurement of Cardiac Troponins." Ann Clin Biochem 38: 423—49.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Collinson, P.O., N. Wiggins, and D.C. Gaze (2001). "Clinical Evaluation of the ACS: 180 Cardiac Troponin I Assay." Ann Clin Biochem 38: 509— 19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cook, R. (1986). "The Mechanisms of Muscle Contraction." CRC Crit Rev Biochem 21: 53—118.[Web of Science][Medline] [Order article via Infotrieve]
  • Corin, S.J., O. Juhasz, L. Zhu, P. Conley, L. Keded, and R. Wade (1994). "Structure and Expression of Human Slow Twitch Skeletal Muscle Troponin I Gene." J Biol Chem 269: 10651—9.[Abstract/Free Full Text]
  • Curtis, B.M. and J.H. O'Keefe (2002). "Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight." Mayo Clin Proc 77: 45—54.[Abstract/Free Full Text]
  • Dare, T.O., H.E. Billings, S.A. Curran, S.A.M. Selway, M.A. Price, T.C. Williams, and M.J. York (1999). "The use of Cardiac Troponin I (cTnI) for the early detection of cardiac damage in Wistar Han Rats." Abstract in Proc ACB Nat Mtg, Manchester, UK.
  • Davilla-Roman, V.G., T.M. Guest, P.G. Tuteur, W.J. Rowe, J.H. Ladenson, and A.S. Jaffe (1997). "Transient Right But Not Left Ventricular Dysfunction After Strenuous Exercise at High Altitude." J Am Coll Cardiol 30: 468—73.[Abstract]
  • de Lemos, J.A., E.M. Antman, and R. Schroder (2000). "Very Early Risk Stratification After Thrombolytic Therapy Using a Bedside Myoglobin Assay and the 12-lead ECG." Am Heart J 140: 373—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Dean, K.J. (1998). "Biochemistry and Molecular Biology of Troponin I and T." Cardiac Markers. A.H.B. Wu, Humana, Totowa, NJ, pp. 193—204.
  • Ebashi, S., T. Wakabayashi, and F. Ebashi (1971). "Troponin and its Components." J Biochem (Tokyo) 69: 441—5.[Free Full Text]
  • Erlacher, P., A. Lercher, J. Falkensammer, E.L. Nassonov, M.I. Samsonov, V.Z. Shtutman, B. Puschendorf, and J. Mair (2001). "Cardiac (Troponin and Beta-Type Myosin Heavy Chain Concentrations in Patients with Polymyositis and Dermatomyositis." Clin Chim Acta 306(1—2): 27— 33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Erwin, M.B. and E.N. Deliargyris (2002). "Cocaine-Associated Chest Pain." Am J Med Sci 324: 37—44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fantoni, M., C. Autore, and C. Del Borgo (2001). "Drugs and Cardiotoxicity in HIV and AIDS." Ann NY Acad Sci 946: 179—99.[Web of Science][Medline] [Order article via Infotrieve]
  • Farah, C.S. and F.C. Reinach (1995). "The Troponin Complex and Regulation of Muscle Contraction." FASEB J 9: 755—67.[Abstract]
  • Ferrans, V.J. (1978). "Overview of Cardiac Pathology in Relation to Anthracycline Cardiotoxicity." Cancer Treat Rep 62: 955—61.[Web of Science][Medline] [Order article via Infotrieve]
  • Fleming, S., L. O'Byrne, J. Finn, H. Grimes, and K.M. Daly (2002). "False-Positive Cardiac Troponin I in a Routine Clinical Population" Am J Cardiol 89: 1212—3.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Flicker, P.F., G.N. Phillips Jr., and C. Cohen (1982). "Troponin and its Interactions with Tropomysin: An Electron Microscopic Study." J Mol Biol 162: 495—501.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fredericks, S., G.K. Merton, M.J. Lerena, P. Heining, N.D. Carter, and D.W. Holt (2001). "Cardiac Troponins and Creatine Kinase Content of Striated Muscle in Common Laboratory Animals." Clin Chim Acta 304: 65—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Frey, N., M. Muller-Bardorff, and H.A. Katus (1998). "Myocardial Damage: Early Detection by Novel Biochemical Markers." Myocardial Damage: The Role of Troponin T. J. C. Kaski, and D. W. Holt, Kluwer Academic Publishers, Boston.
  • Gerhardt, W. and L. Ljungdahl (1998). "Troponin T: A Sensitive and Specific Diagnostic and Prognostic Marker of Myocardial Damage." Clin Chim Acta 272: 47—57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Giantris, A., L. Abdurrahman, A. Hinkle, B. Asselin, and S.E. Lipshultz (1998). "Anthracycline-induced Cardiotoxicity in Children and Young Adults." Crit Rev Oncol/Hematol 27: 53—68.[Web of Science][Medline] [Order article via Infotrieve]
  • Gottlieb, R.A., K.O. Burleson, R.A. Kloner, B.M. Babior, and R.L. Engler (1994). "Reperfusion injury induces apoptosis in rabbit cardiomyocytes." J Clin Invest 94: 1621—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Greaser, M. and J. Gergely (1973). "Purification and Properties of the Components from Troponin." J Biol Chem 248: 2125—33.[Abstract/Free Full Text]
  • Gulati, J., A.B. Akella, S.D. Nikolic, V. Starc, and F. Siri (1994). "Shifts in Contractile Regulatory Protein Subunits Troponin T and Troponin I in Cardiac Hypertrophy. Biochem Biophys Res Commun 202: 384—90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Haller, C., J. Zehelein, A. Remppis, M. Muller-Bardorff, and H.A. Katus (1998). "Cardiac Troponin T in Patients with Endstage Renal Disease: Absence of Expression in Truncal Skeletal Muscle." Clin Chem 44: 930—8.[Abstract/Free Full Text]
  • Herman, E.H. and V.J. Ferrans (1998). "Preclinical Models of Cardiac Protection from Anthracycline-Induced Cardiotoxicity." Semin Oncol 25 (Suppl 10): 15—21.[Web of Science][Medline] [Order article via Infotrieve]
  • Herman, E.H. and V.J. Ferrans (2001). "The Use of Cardiac Biomarkers for the Detection of Drug-Induced Myocardial Damage." Markers in Cardiology: Current and Future Clinical Applications, J. E. Adams III, F. S. Apple, A. S. Jaffe, and A. H. B. Wu Futura Publishing Co, Armonk, New York.
  • Herman, E.H., S.E. Lipshultz, N. Rifai, J. Zhang, T. Papoian, X. Yuz, K. Takeda, and V.J. Ferrans (1998). "Use of Cardiac Troponin T Levels as an Indicator of Doxorubicin-Induced Cardiotoxicity." Cancer Res 58: 195—7.[Abstract/Free Full Text]
  • Herman, E.H., J. Zhang, S. Lipshultz, N. Rifai, D. Chadwick, K. Takeda, Z.X. Yu and V.J. Ferrans (1999). "Correlation Between Serum Levels of Cardiac Troponin-T and the Severity of the Chronic Cardiomypoathy Induced by Doxorubicin." J Clin Oncol 17: 2237—43.[Abstract/Free Full Text]
  • Herman, E.H., J. Zhang, N. Rafai, S.E. Lipshultz, B.B. Hasinoff, D.P. Chadwick, A. Knapton, J. Chai, and V.J. Ferrans (2001). "The use of Serum Levels of Cardiac Troponin T to Compare the Protective Activity of Dexrozoxane Against Doxorubicin- and Mitoxantrone-Induced Cardiotoxicity. Cancer Chemother Pharmacol 48: 297—304.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jaffe, A.S. (2001) "Elevations in Cardiac Troponin Measurements: False False-Positives. The Real Truth." Cardiovasc Toxicol 1: 87—92.
  • Jaffe, A.S., J. Ravkilde, R. Roberts, U. Naslund, F.S. Apple, M. Galvani, and H. Katus (2000). "It's Time for a Change to a Troponin Standard." Circulation 102: 1216—20.[Free Full Text]
  • Joint European Society of Cardiology/American College of Cardiology Committee (2000a). "Myocardial Infarction Redefined—A Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction." J Amer Coll Cardiol 36: 959—68.[Free Full Text]
  • Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction ( 2000b). "Myocardial Infarction Redefined—A Consensus Document." Eur Heart J 21: 1502— 13.[Abstract/Free Full Text]
  • Karczewski, P., S. Bartel, and E.-G. Krause (1993). "Protein Phosphorylation in the Regulation of Cardiac Contractibility and Vascular Smooth Muscle Tone." Curr Opin Nephrol Hypertens 2: 33—40.[Medline] [Order article via Infotrieve]
  • Katrukha, A.G., A.V. Bereznikova, T.V. Esakova, K. Petterson, T. Lovgren and M.E. Severina (1997). "Troponin I is Released in Bloodstream of patients with Acute Myocardial Infarction Not in Free Form but as a Complex." Clin Chem 43: 1379—85.[Abstract/Free Full Text]
  • Katus, H.A., A. Remppis, T. Scheffold, K.W. Diederich, and W. Kuebler (1991). "Intracellular Compartmentation of Cardiac Troponin T and its Release Kinetics in Patients with Reperfused and Nonreperfused Myocardial Infarction." Am J Cardiol 67: 1360—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Katus, H.A., T. Scheffold, A. Remppis, and J. Zehlein (1992). "Proteins of the Troponin Complex." Lab Med 23: 311—7.[Web of Science]
  • Kawakami, T., C. Lowbeer, G. Valen, and J. Vaage (1999). "Post-Ischemic Dysfunction Does Not Correlate with Release of Cardiac Troponin T in Isolated Rat Hearts." Acta Physiol Scand 167: 23—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Keefe, D.L. (2002). "Trastuzumab-Associated Cardiotoxicity." Cancer 95(7): 1592—600.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kim, M. and K. Kim (1999). "Elevation of Cardiac Tropnin I in the Acute Stage of Kawasaki Disease." Pedia Cardiol 20: 184—8.[CrossRef]
  • Kitsis, R.N. and J. Scheuer (1996). "Functional Significance of Alterations in Cardiac Contractile Protein Isoforms." Clin Cardiol 19: 9—18.[Web of Science][Medline] [Order article via Infotrieve]
  • Knoblock, R.J., C.M. Lehman, R.A. Smith, F.S. Apple, and W.L. Roberts (2002). "False-positive AxSYM cardiac Troponin I Results in a 53-Year old Woman." Arch Pathol Lab Med 126: 606—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Kontos, M.C., F.P. Anderson, J.P. Ornato, J.L. Tatum, and R.L. Jesse (2002). "Utility of Troponin I in Patients with Cocaine-Associated Chest Pain." Acad Emerg Med 9: 1007—13.[Web of Science][Medline] [Order article via Infotrieve]
  • Krischer, J.P., S. Epstein, D.D. Cuthbertson, A.M. Goorin, M.L. Epstein, and S.E. Lipshultz (1997). "Clinical Cardiotoxicity Following Anthracycline Treatment for Childhood Cancer: The Pediatric Oncology Group Experience." J Clin Oncol 15(4): 1544—52.[Abstract]
  • Krishan, K. and G.K. Dhoot (1996). "Changes in Some Troponin and Insulin-Like Growth Factor Messenger Ribonucleic Acids in Regenerating and Denervated Skeletal Muscles." J Muscle Res Cell Motil 17: 513— 21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kruit, W.H., K. J. Punt, S.H. Goey, P.H. de Mulder, D.C. van Hoogenhuyze S. C. Henzen-Logmans, and G. Stoter (1994). "Cardiotoxicity as a Dose-Limiting Factor in a Schedule of High Dose Bolus Therapy with Interleukin-2 and Alpha-interferon. An Unexpectedly Frequent Complication." Cancer 74(10): 2850—6.
  • Leavis, P. and J. Gergely (1984). "Thin Filament Proteins and Thin Filament Linked Regulation of Vertebrate Muscle Contraction." CRC Crit Rev Biochem 16: 235—305.[Web of Science][Medline] [Order article via Infotrieve]
  • Levin, E.R., D.G. Gardner, and W.K. Samson (1998). "Natriuretic Peptides." New Engl J Med 339: 321—8.[Free Full Text]
  • Lindahl, B., H. Toss, A. Siegbahn, P. Venge, and L. Wallentin (2000). "Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease. New Engl J Med 343: 1139—47.[Abstract/Free Full Text]
  • Lipshultz, S.E., N. Rafai, S.E. Sillan, S.R. Lipsitz, V. Dalton, D.B. Socks, and M.E. Ottlinger (1997). "Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury." Circulation 96(8): 2641— 48.[Web of Science]
  • Lobetti, R., E. Dvir, and J. Pearson (2002). "Cardiac Troponins in Canine Babesiosis." J Vet Intern Med 16: 63—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lodish, H., A. Berk, L. Zipursky, P. Matsudiara, D. Baltimore and J. Darnell (1995). Molecular Cell Biology. 3rd ed, WH Freeman, New York, pp. 1021—1032.
  • Luchner, A., T.L. Stevens, D.D. Borgeson, M. Redfield, C.M. Wei, and J.C. Brunett Jr (1998). "Differential Atrial and Ventricular Expression of Myocardial BNP During Evolution of Heart Failure." Am J Physiol 274: H1684—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Machackova J., M. Adamcova, Y. Mazurova, R. Hrdina, and M. Noblis (2001). "Evaluation of Cardiac Effects of the New Antineoplastic Drug Dimethoxybenfluron in the Rabbit." Physiol Res 50: 491—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Maeda, K., T. Tsutomoto, A. Wada, T. Hisanaga, and M. Kinoshita (1998). "Plasma Brain Natriuretic Peptide as a Biochemical Marker of High Left Ventricular End-Diastolic Pressure in Patients with Symptomatic Left Ventricular Dysfunction." Am Heart J 135: 825—32.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mahla, E., K. Tiesenhausen, P. Rehak, S. Fruhwald, P. Purstner, and H. Metzler (2000). "Perioperative Myocardial Cell Injury: The Relationship Between Troponin T and Cortisol." J Clin Anes 12: 208—12.[CrossRef]
  • Mair, J. (1997). "Progress in Myocardial Damage Detection: New Biochemical Markers for Clinicians." Crit Rev Clin Lab Sci 34: 1—66.[Web of Science][Medline] [Order article via Infotrieve]
  • Mair, J., I. Wagner, B. Morass, L. Fridrich, P. Lechleitner F. Dienstl C. Calzolari, C. Larue, and B. Puschendorf (1995). "Cardiac Troponin I Release Correlates with Myocardial Infarction Size." Eur J Clin Chem Clin Biochem 33: 869—72.[Web of Science][Medline] [Order article via Infotrieve]
  • Maisel, A.S., P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H.B. Wu et al. (2002). "Rapid Measurement of B-type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure." New Engl J Med 347: 161—7.[Abstract/Free Full Text]
  • Malouf, N.N., D. McMahon, A.E. Oakeley, and P.A. Anderson (1992). "A Cardiac Troponin T Epitope Conserved Across Phyla." J Biol Chem 267: 9269—74.[Abstract/Free Full Text]
  • Martin, A.F. (1981). "Turnover of Cardiac Troponin Subunits." J Biol Chem 256: 964—8.[Abstract/Free Full Text]
  • Masuda, T., K. Sato, S. Yamamoto, N. Matsuyama, T. Shimohama, A. Matsunaga, S. Obuchi, Y. Shiba, S. Shimizu, and T. Izumi (2002). "Sympathetic Nervous Activity and Myocardial Damage Immediately after Subarachnoid Hemorrhage in a Unique Animal Model." Stroke 33: 1671—6.[Abstract/Free Full Text]
  • McDonough, J.L., D.K. Arrell, and J.E. VanEyk (1999). "Troponin I Degradation and Covalent Complex Formation Accompanies Myocardial Ischemia/Reperfusion Injury." Circ Res 84: 9—20.[Abstract/Free Full Text]
  • McLeurin, M., F.S. Apple, T.D. Henry et al. (1996). "Cardiac Troponin I and T Concentrations in Patients with Cocaine-Associated Chest Pain." Ann Clin Biochem 33: 183—6.[Web of Science][Medline] [Order article via Infotrieve]
  • McLeurin, M.D., F.S. Apple, E.M. Voss, C.A. Herzog, and S.W. Sharkey (1997). "Cardiac Troponin I, Cardiac Troponin T and Creatine Kinase MB in Dialysis Patients Without Ischemic Heart Disease: Evidence of Cardiac Troponin T Expression in Skeletal Muscle." Clin Chem 43: 976— 82.[Web of Science]
  • Mesnard, L., F. Samson, I. Espinasse, J. Durand, J.Y. Neveux, and J.J. Mercadier (1993). "Molecular Cloning and Developmental Expression of Human Cardiac Troponin T." FEBS Lett 328: 139—44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Messner, B., H. Baum, P. Fischer, S. Quasthoff, and D. Neumeier (2000). "Expression of Messenger RNA of the Cardiac Isoforms of Troponin T and I in Myopathic Skeletal Muscle." Clin Chem 114: 544—9.
  • Nadal-Ginard, B. and V. Mahdaui (1989). "Molecular Basis of Cardiac Performance." J Clin Invest 84: 1693—700.[Web of Science][Medline] [Order article via Infotrieve]
  • Nosanchuk, J.S. (1999). "False Increases of Troponin I Attributable to Incomplete Separation of Serum. Clin Chem 45: 714.[Free Full Text]
  • O'Brien, P.J., G.W. Dameron, M.L. Beck Y.J. Kang, B.K. Erickson, and T. H. Di Battista K.E. Miller K.N. Jackson and S. Mittelstadt (1997a). " Cardiac Troponin T is a Sensitive, Specific Biomarker of Cardiac Injury in Laboratory Animals." Lab Anim Sci 47: 486—95.[Web of Science][Medline] [Order article via Infotrieve]
  • O'Brien, P.J., G.W. Dameron, M.L. Beck, and M. Brandt (1998). "Differential Reactivity of Cardiac and Skeletal Muscles from Various Species in Two Generations of Cardiac Troponin T Immunoassays." Res Vet Sci 65: 135—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • O'Brien, P., Y. Lanott, and J. Ladenson (1997b). "Differential Reactivity of Cardiac and Skeletal Muscle from Various Species in a Cardiac Troponin-I Immunoassay." Clin Chem 43: 2333—8.[Abstract/Free Full Text]
  • Ooi, D.S., P.A. Isotalo, and J.P. Veinot (2000). "Correlation of Antemortum Serum Creatine Kinase, Creatine Kinase-MB, Troponin I, and Troponin T with Cardiac Pathology." Clin Chem 46: 338—44.[Abstract/Free Full Text]
  • Patel, V.B., R. Ajmal, R.A. Sherwood, A. Sullivan, P.J. Richardson, and V.R. Preedy (2001). "Cardioperotective Effect of Propanolol from Alcohol Induced Heart Muscle Damage as Assessed by Plasma Cardiac Troponin, T. Alcohol. Clin Exp Res 25: 882—9.[CrossRef]
  • Pearlstone, J.R., M.R. Carpenter, and L.B. Smille (1986). "Amino Acid Sequence of Rabbit Cardiac Troponin T." J Biol Chem 261: 16795—810.[Abstract/Free Full Text]
  • Pinelli, A., S. Trivulzio, L. Tomasoni, B. Bertolini, S. Brenna, and E. Bonacina (2002). "Cardiac Necrosis Markers Associated with Low Nitric Oxide Levels in the Plasma of Rabbits after Treatment with Vasopression: Protective Effects of Nitroglycerin Administration." Pharmacol Res 45: 427—34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Plebani, M., M. Mion, S. Altinier, M.A. Girotto, G. Baldo, and M. Zaninotto (2002). "False-Positive Troponin I Attributed to a Macrocomplex." Clin Chem 48: 677—8.[Free Full Text]
  • Potter, J.D., Z. Sheng, B.-S. Pan, and J. Zhao (1995). "A Direct Regulatory Role for Troponin T and a Dual Role for Troponin C in the Ca+2 Regulation of Muscle Contraction." J Biol Chem 270: 2557—62.[Abstract/Free Full Text]
  • Quirk, P.G., V.B. Patchell, Y. Gao, B.A. Levine, and S.V. Perry (1995). "Sequential Phosphorylation of Adjacent Serine Residues on the n-Terminal Region of Cardiac Troponin-I: Structure Activity Implications of Ordered Phosphorylation." FEBS Lett 370: 175—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Remme, W.J. and K. Swedberg (2002). "Comprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology." Eur J Heart Fail 4: 11—22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Remppis, A., P. Ehlermann, E. Giannitis, T. Greten, P. Most, M. Muller-Bardoff, and H.A. Katus (2000). "Cardiac Troponins at 96 Hours Reflect Myocardial Infarct Size: A Pathoanatomical Study." Cardiology 93: 249—53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Remppis, A., T. Scheffold, J. Greten, M. Haass, T. Greten, W. Kubler, and H.A. Katus (1995). "Intracellular Compartmentation of Troponin T: Release Kinetics After Global Ischemia and Calcium Paradox in the Isolated Perfused Rat Heart." J Mol Cell Cardiol 27(2): 793—803.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ricchiuti, V., E.M. Voss, A. Ney, M. Odland, P.A.W. Anderson, and F.S. Apple (1998). "Cardiac Troponin T Isoforms Expressed in Renal Diseased Skeletal Muscle will not Cause False-Positive Results by the Second Generation Cardiac Troponin T Assay by Boehringer Mannheim." Clin Chem 44: 1919—24.[Abstract/Free Full Text]
  • Ridker, P.M., N. Rifai, L. Rose, J.E. Buring, and N.R. Cook (2002). "Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events." New Engl J Med 347: 1557—65.[Abstract/Free Full Text]
  • Roberts, R. (1990). "Enzymatic Estimation of Infarct Size: Thrombolysis Induced its Demise: Will it Now Rekindle its Renaissance?" Circulation 81: 707—10.[Free Full Text]
  • Saggin, L., L. Gorza, S. Ausoni, and S. Schiaffino (1990). "Cardiac Troponin T in Developing, Regenerating and Denervated Rat Skeletal Muscle." Development 110: 547—54.[Abstract/Free Full Text]
  • Sakamoto, H., H. Nishimura, K. Imataka K. Ieki, T. Horie, and J. Fujii (1996). "Abnormal Q Wave, ST-Segment Elevation, T-Wave Inversion, and Widespread Focal Myocytolysis Associated with Subarachnoid Hemorrhage." Jpn Circ J 60(4): 254—7.[CrossRef][Medline] [Order article via Infotrieve]
  • Sakr, Y.L., I. Ghosn, and J.L. Vincent (2002). "Cardiac Manifestations after Subarachnoid Hemorrhage: A Systematic Review of the Literature." Prog Cardiovasc Dis 45(1): 67—80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sasse, S., N.J. Brand, P. Kyprianou, G.K. Dhoot, R. Wade, M. Arai, M. Periasamy M.H. Yacoub, and P.J. Barton (1993). "Troponin I Gene Expression During Human Cardiac Development and in End-Stage Heart Failure." Circ Res 72: 932—8.[Abstract/Free Full Text]
  • Scripps (1994). SCRIPPS Reports: Drug Withdrawal from Sale. 2nd ed. PJB Publications, Richmond, Surrey, UK.
  • Seino, Y., Y. Tomita, Y. Nagai, Y. Kusama, H. Hayakawa, T. Sasaki, and I. Horii (1993). "Cardioprotective Effects of ACE-Inhibitor (cilazapril) on Adriamycin Cardiotoxicity in Spontaneously Hypertensive Rats." Circulation 88: 1633.
  • Smith, S.C., J.H. Ladenson, J.W. Mason, and A.S. Jaffe AS (1997). "Elevations of Cardiac Troponin I Associated with Myocarditits. Experimental and Clinical Correlates." Circulation 95(1): 163—8.[Abstract/Free Full Text]
  • Sutherland, C.J., K.A. Esser, V.L. Elsom, M.L. Gordon, and E.C. Hardeman (1993). "Identification of a Program of Contractile Protein Gene Expression Initiated Upon Skeletal Muscle Differentiation." Dev Dyn 196: 25—36.[Web of Science][Medline] [Order article via Infotrieve]
  • Thomas, S.A., J.A. Fallavollita, T.C. Lee et al. (1999). "Absence of Troponin I Degradation of Altered Sarcoplasmic Reticulum Uptake Protein Expression after Reversible Ischemia in Swine." Circ Res 85: 446—56.[Abstract/Free Full Text]
  • Tobacman, L.S. and R. Lee (1987). "Isolation and Functional Comparison of Bovine Cardiac Troponin Isoforms." J Biol Chem 262: 4059—64.[Abstract/Free Full Text]
  • Townsend, P.J., H. Farza, C. MacGeoch, K.N.K. Spurr, R. Wade, R. Gahlaman, M. Yocoub, and P.J. Barton (1994). "Human Cardiac Troponin T Identification of Fetal Isoforms and Assignment of the TNNT2 Locus to Chromosome 1q." Genomics 21: 311—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsung, J.S. and S.S. Tsung (1986). "Creatine Kinase Isoenzymes in Extracts of Various Human Skeletal Muscles." Clin Chem 32: 1568—70.[Abstract/Free Full Text]
  • Uettwiller-Geiger, D., A.H. Wu, F.S. Apple, A.W. Jevans, P. Nenge, M.D. Olson, C. Dartte, D.L. Woodrum, and S. Roberts Chan (2002). "Multicenter Evaluation of an Automated Assay for Troponin I. Clin Chem 48: 869—76.[Abstract/Free Full Text]
  • Vallins, W.J., N.J. Brand, N. Dabhade, G. Butler-Browne, M.H. Yacoub, and P.J.R. Barton (1990). "Molecular Cloning of Human Cardiac Troponin I Using Polymerase Chain Reaction." FEBS Lett 270: 57—61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Venema, R.C. and J.F. Kao (1993). "Protein Kinase C Mediated Phosphorylation of Troponin I and C-Protein in Isolated Myocardial Cells is Associated with Inhibition of Myofibrillar Actinomysin Mg ATPase." J Biol Chem 268: 2705—11.[Abstract/Free Full Text]
  • Von Hoff, D.D., M. Rozencweig, and M. Piccart (1982). "The Cardiotoxicity of Anticancer Agents." Semin Oncol 9: 23—33.[Web of Science][Medline] [Order article via Infotrieve]
  • Voss, E.M., S.W. Sharkey, A.E. Gernert, M.M. Murakami, R.B. Johnston, C.C. Hsieh, and F.S. Apple (1995). "Human and Canine Cardiac Troponin T and Creatine Kinase MB Distribution in Normal and Diseased Myocardium: Infarct Sizing Using Serum Profiles." Arch Pathol LAB Med 119: 799—806.[Web of Science][Medline] [Order article via Infotrieve]
  • Wade, R., R. Eddy, T.B. Shows, and L. Kedes (1990). "cDNA Sequence, Tissue Specific Expression and Chromosomal Mapping of the Human Slow-Twitch Skeletal Muscle Isoform of Troponin I." Genomics 7: 346—57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wade, R. and L. Kedes (1989). "Developmental Regulation of Contractile Protein Genes." Ann Rev Physiol 51: 179—88.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Welsh, T.M., G.D. Kukes, andL.M. Sandweiss (2002). "Differences of Creatine Kinase MB and Cardiac Troponin I Concentrations in Normal and Diseased Human Myocardium." Ann Clin Lab Sci 32(1): 44—9.[Abstract/Free Full Text]
  • Wilkinson, J.M. and R.J.A. Grand (1978). "Comparison of Amino Acid Sequences of Troponin I from Different Striated Muscles." Nature 271: 31—5.[CrossRef][Medline] [Order article via Infotrieve]
  • Wu, A.H. (1994). "Cardiac Troponin T: Biochemical, Analytical and Clinical Aspects." J Clin Immmunoassay 17: 45—8.
  • Wu, A.H. (1999a). "Biochemical Markers of Cardiac Damage: Form Traditional Enzymes to Cardiac Specific Proteins." Scand J Clin Lab Invest 50 (Suppl. 230): 74—82.
  • Wu, A.H., F.S. Apple, W.B. Gibler, R.L. Jesse, M.M. Warshaw, and R. Valdes Jr (1999b)." National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases." Clin Chem 45: 1104—21.[Abstract/Free Full Text]
  • Wu, A.H., Y.J. Feng, R. Moore, F.S. Apple, P.H. Mcpherson, K.F. Buechler, and G. Bodor (1998). "Characterisation of Cardiac Troponin Subunit Release into Serum after Acute Myocardial Infarction and Comparison of Assays for Troponin T and I." Clin Chem 44: 1198—208.[Abstract/Free Full Text]
  • Wu, H.B. and L. Ford (1999). "Release of Cardiac Troponin in Acute Coronary Syndromes: Ischemia or Necrosis?" Clin Chim Acta 284: 161—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zot, A.S. and J.D. Potter (1987). "Structural Aspects of Troponin-Tropomyosin Regulation of Skeletal Muscle Contraction." Ann Rev Biophys Chem 16: 535—59.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 1, 106-121 (2004)
DOI: 10.1080/01926230490261302
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Bian, M. Sun, M. Silver, K. K. L. Ho, M. A. Marchionni, A. O. Caggiano, J. R. Stone, I. Amende, T. G. Hampton, J. P. Morgan, et al.
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H1974 - H1983.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. S. Apple, M. M. Murakami, R. Ler, D. Walker, M. York, and for the HESI Technical Committee of Biomarkers Wor
Analytical Characteristics of Commercial Cardiac Troponin I and T Immunoassays in Serum from Rats, Dogs, and Monkeys with Induced Acute Myocardial Injury
Clin. Chem., December 1, 2008; 54(12): 1982 - 1989.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. M. Horacek, M. Tichy, R. Pudil, and L. Jebavy
Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity
Ann. Onc., September 1, 2008; 19(9): 1656 - 1657.
[Full Text] [PDF]

Home page
 Toxicol PatholHome page
J. Zhang, A. Knapton, S. E. Lipshultz, J. L. Weaver, and E. H. Herman
Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury
Toxicol Pathol, February 1, 2008; 36(2): 277 - 278.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
A. Lyshchik, A. C. Fleischer, J. Huamani, D. E. Hallahan, M. Brissova, and J. C. Gore
Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast-Enhanced High-Frequency Ultrasonography
J. Ultrasound Med., November 1, 2007; 26(11): 1575 - 1586.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. K. Dunnick, K. A. Thayer, and G. S. Travlos
Inclusion of Biomarkers for Detecting Perturbations in the Heart and Lung and Lipid/Carbohydrate Metabolism in National Toxicology Program Studies
Toxicol. Sci., November 1, 2007; 100(1): 29 - 35.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
N. Mayer-Hamblett, B. W. Ramsey, and R. A. Kronmal
Advancing Outcome Measures for the New Era of Drug Development in Cystic Fibrosis
Proceedings of the ATS, August 1, 2007; 4(4): 370 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
M. York, C. Scudamore, S. Brady, C. Chen, S. Wilson, M. Curtis, G. Evans, W. Griffiths, M. Whayman, T. Williams, et al.
Characterization of Troponin Responses in Isoproterenol-Induced Cardiac Injury in the Hanover Wistar Rat
Toxicol Pathol, June 1, 2007; 35(4): 606 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
Z.-X. Jin, J.-J. Zhou, M. Xin, D.-R. Peng, X.-M. Wang, S.-H. Bi, X.-F. Wei, and D.-H. Yi
Postconditioning the Human Heart with Adenosine in Heart Valve Replacement Surgery
Ann. Thorac. Surg., June 1, 2007; 83(6): 2066 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Atri
New Technologies and Directed Agents for Applications of Cancer Imaging
J. Clin. Oncol., July 10, 2006; 24(20): 3299 - 3308.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
D. B. Walker
Serum Chemical Biomarkers of Cardiac Injury for Nonclinical Safety Testing
Toxicol Pathol, January 1, 2006; 34(1): 94 - 104.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
B. A. Wetmore and B. A. Merrick
Invited Review: Toxicoproteomics: Proteomics Applied to Toxicology and Pathology
Toxicol Pathol, October 1, 2004; 32(6): 619 - 642.
[Abstract] [PDF]

Home page
 Toxicol SciHome page
J. Dunnick, J. Johnson, J. Horton, and A. Nyska
Bis(2-chloroethoxy)methane-Induced Mitochondrial and Myofibrillar Damage: Short-Term Time-Course Study
Toxicol. Sci., September 1, 2004; 81(1): 243 - 252.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wallace, K. B.
Right arrow Articles by York, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallace, K. B.
Right arrow Articles by York, M. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?